
A compound heterozygous mutation of the alkaline phosphatase ALPL gene causes hypophosphatasia in a Han Chinese family
Hypophosphatasia (HPP) is a uncommon hereditary systemic illness that’s characterised by faulty bone and/or dental mineralization, and is brought on by mutations within the alkaline phosphatase gene (ALPL). The current examine investigated the ALPL mutation in a Chinese language Han household with HPP and studied the pathogenesis of the mutations of the ALPL gene. DNA was extracted from peripheral venous blood of the members of the family. Sanger sequencing was used to display the mutations.
Associations between pathogenesis for each mutations had been analyzed by bioinformatics, subcellular localization, measurement of enzyme exercise and western blotting. Sanger sequencing revealed the compound heterozygous mutations c.203C>T (p.T68M) and c.571G>A (p.E191Okay). The mutations had been positioned at exon four and 6 of the ALPL gene and had been predicted by Polyphen-2 evaluation to be dangerous. Protein evaluation indicated a lower in mature protein manufacturing and decrease enzyme exercise in 293T cells transfected with plasmids carrying the mutations.
The ALPL gene was cloned into the pcDNA3.1(+) vector and mutant plasmids ALPL-pT68M and ALPL-pE191Okay had been constructed. Immunofluorescence noticed in cells transfected with the ALPL-pE191Okay mutant plasmid was primarily positioned within the cell membrane. Nonetheless, staining within the cytoplasm was elevated in contrast with the wild kind, and nearly no fluorescence was recognized in 293T cells transfected with the ALPL-pT68M mutant plasmid. The current findings demonstrated that the compound heterozygous c.571G>A and c.203C>T mutations might contribute to childhood HPP by leading to mislocalization, decreased protein expression and lack of enzyme exercise in a Han Chinese language household. The outcomes of the present examine might present insights into the potential molecular mechanism of HPP.
Identification of Signatures of Choice by Entire-Genome Resequencing of a Chinese language Native Pig
Identification of genomic signatures of choice that assist reveal genetic mechanisms underlying traits in domesticated pigs is of significance. Anqing six-end-white pig (ASP), a consultant of the native breeds in China, has many distinguishing phenotypic traits. To establish the genomic signatures of choice of the ASP, whole-genome sequencing of 20 ASPs produced 469.01 Gb of sequence knowledge and greater than 26 million single-nucleotide polymorphisms.
Combining these knowledge with the out there complete genomes of 13 Chinese language wild boars, 157 chosen areas harboring 48 protein-coding genes had been recognized by making use of the polymorphism ranges (θπ) and genetic differentiation (F ST ) based mostly cross approaches.
The genes discovered to be positively chosen in ASP are concerned in essential organic processes reminiscent of coat colour ( MC1R ), salivary secretion ( STATH ), copy ( SPIRE2 , OSBP2 , LIMK2 , FANCA , and CABS1 ), olfactory transduction ( OR5K4 ), and development ( NPY1R , NPY5R , and SELENOM ). Our analysis elevated the data of ASP phenotype-related genes and assist to enhance our understanding of the underlying organic mechanisms and supply helpful genetic assets that allow efficient use of pigs in agricultural manufacturing.
Is CHEK2 a moderate-risk breast most cancers gene or the youthful sister of Li-Fraumeni?
The CHEK2 gene is usually thought-about as a average breast most cancers gene with the outcome that many clinicians have a slender focus. We current the 10-year journey of a person who had 5 completely different cancers and had iterative genetic testing together with for Li-Fraumeni syndrome, finally to find a pathogenic variant within the CHEK2 gene, presumably explaining his quite a few cancers. This prognosis supplied him closure which he had desperately searched for properly over a decade.
A pathogenic variant within the CHEK2 gene can doubtlessly clarify these cancers due to its operate as a tumour suppressor gene. Consideration is warranted of what this implies for people with CHEK2 variants who might develop a number of cancers, their prognosis and whether or not completely different therapy modalities reminiscent of chemotherapy, radiotherapy or goal brokers would wish modification. We encourage extra analysis into the various faces of the CHEK2 gene and the potential for predisposition to a number of cancers.
Purposeful classification of prostate most cancers‑related miRNAs by CRISPR/Cas9‑mediated gene knockout
The purpose of the current examine was to make use of the clustered repeatedly interspaced brief palindromic repeats (CRISPR) and CRISPR‑related (Cas) 9‑mediated gene knockout know-how for the speedy classification of the differential operate of micro (mi)RNAs screened utilizing miRNA expression profiling by microarray. The rational design of single information RNAs for the CRISPR/Cas9 system was verified to operate in human LNCaP cells with speedy and environment friendly goal gene modifying.
miRNA (miR)‑205, miR‑221, miR‑222, miR‑30c, miR‑224, miR‑455‑3p, miR‑23b and miR‑505 had been downregulated in sufferers with prostate most cancers (PCa) and had been experimentally validated to operate as tumor suppressors in prostate most cancers cells, affecting tumor proliferation, invasion and cardio glycolysis. As well as, the info of the current examine advised that miR‑663a and mfiR‑1225‑5p had been upregulated in prostate most cancers tissues and cell proliferation of miR‑663a and miR‑1225‑5p knockout PCa cells was considerably decrease in contrast with miR‑NC cells. Moreover, knockout of miR‑1225‑5p and miR‑663a considerably decreased the lactate manufacturing in LNCaP cells in vitro.
In conclusion, the current examine supplied a easy and environment friendly methodology for quickly classifying miRNA operate by making use of CRISPR/Cas9 in LNCaP cells. The current examine advised, for the primary time to the most effective of the authors’ data, that the aberrant expression of miR‑663a and miR‑1225‑5p could also be concerned with the development of prostate most cancers, implying their potential as candidate markers for any such most cancers. Nonetheless, the exact function of miR‑663a and miR‑1225‑5p in accelerating the event of prostate most cancers and selling tumor development stays to be elucidated.

Genetic and Medical Traits of Sufferers With Homozygous and Compound Heterozygous Familial Hypercholesterolemia From Three Totally different Populations: Case Sequence
- Homozygous familial hypercholesterolemia (HoFH) and compound heterozygous familial hypercholesterolemia (cHeFH) are uncommon problems generated by disease-causing variants in each alleles of the LDLRor different familial hypercholesterolemia (FH)-related genes. HoFH and cHeFH are characterised by severely elevated low-density lipoprotein-cholesterol (LDL-C), incessantly resulting in early heart problems.
- We investigated the genetic and scientific traits of HoFH and cHeFH sufferers from the Slovenian FH registry and/or those that had been beforehand recognized or managed at our establishment (Slovenian, Pakhtun and Albanian ethnicity), the place genetic testing just isn’t out there. Our examine contains seven sufferers. Their median age on the time of scientific prognosis was 6.three years (2.9-12.9 years); 2/7 had been females.
- Two sufferers had been recognized by the common FH screening and 5 sufferers had been recognized as a result of presence of xanthomas. All of the mutations are current in LDLRgene: 7 completely different genotypes for HoFH (p.Cys167Leu, p.Asp178Asn, p.Cys243Tyr, p.Gly549Asp, p.Cys27Trp, p.Ile585Thr and p.Val797Met) and p.Gly549Asp/p.Gln384Professional genotype for cHeFH affected person. The median preliminary stage of LDL-C was 17.zero mmol/L [655 mg/dL] (vary 7.6-21.6 mmol/L). The HoFH/cHeFH sufferers are clinically and genetically very various.
- The scientific standards (as Simon Broome standards) could be relevant already in youngsters to lift suspicion of FH however in some circumstances fail to tell apart heterozygous FH and HoFH/cHeFH sufferers. Nonetheless, genetic testing is useful in confirming the prognosis, additionally for a immediate consciousness, higher compliance to therapy and household screening.
![]() Vav 1 Oncogene (VAV1) Antibody |
|||
20-abx327434 | Abbexa |
|
|
![]() Vav 1 Oncogene (VAV1) Antibody |
|||
20-abx327966 | Abbexa |
|
|
![]() Vav 1 Oncogene (VAV1) Antibody |
|||
20-abx329103 | Abbexa |
|
|
![]() Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human) |
|||
4-PAC213Hu01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1) |
![]() Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse) |
|||
4-PAC213Mu01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1) |
![]() Recombinant Vav 1 Oncogene (VAV1) |
|||
4-RPC213Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Vav 1 Oncogene expressed in: E.coli |
![]() Recombinant Vav 1 Oncogene (VAV1) |
|||
4-RPC213Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Vav 1 Oncogene expressed in: E.coli |
![]() Proto-Oncogene Vav (VAV1) Antibody |
|||
abx011903-100ug | Abbexa | 100 ug | EUR 411 |
![]() Proto-Oncogene Vav (VAV1) Antibody |
|||
20-abx012888 | Abbexa |
|
|
![]() Proto-Oncogene Vav (VAV1) Antibody |
|||
20-abx000854 | Abbexa |
|
|
![]() Proto-Oncogene Vav (VAV1) Antibody |
|||
abx239377-100ug | Abbexa | 100 ug | EUR 551 |
![]() Proto-Oncogene Vav (VAV1) Antibody |
|||
20-abx141277 | Abbexa |
|
|
![]() Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), APC |
|||
4-PAC213Hu01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with APC. |
![]() Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), Biotinylated |
|||
4-PAC213Hu01-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with Biotin. |
![]() Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), Cy3 |
|||
4-PAC213Hu01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with Cy3. |
![]() Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), FITC |
|||
4-PAC213Hu01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with FITC. |
![]() Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), HRP |
|||
4-PAC213Hu01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with HRP. |
![]() Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), PE |
|||
4-PAC213Hu01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with PE. |
![]() Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), APC |
|||
4-PAC213Mu01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with APC. |
![]() Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), Biotinylated |
|||
4-PAC213Mu01-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with Biotin. |
![]() Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), Cy3 |
|||
4-PAC213Mu01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with Cy3. |
![]() Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), FITC |
|||
4-PAC213Mu01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with FITC. |
![]() Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), HRP |
|||
4-PAC213Mu01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with HRP. |
![]() Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), PE |
|||
4-PAC213Mu01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with PE. |
![]() Mouse Vav 1 Oncogene (VAV1) Protein |
|||
20-abx168844 | Abbexa |
|
|
![]() Human Vav 1 Oncogene (VAV1) Protein |
|||
20-abx167017 | Abbexa |
|
|
![]() Proto-Oncogene Vav (VAV1) Protein |
|||
20-abx263391 | Abbexa |
|
|
![]() Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), APC-Cy7 |
|||
4-PAC213Hu01-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with APC-Cy7. |
![]() Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), APC-Cy7 |
|||
4-PAC213Mu01-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with APC-Cy7. |
![]() Human Vav 1 Oncogene(VAV1) ELISA Kit |
|||
QY-E04499 | Qayee Biotechnology | 96T | EUR 361 |
![]() Vav 1 Oncogene Phospho-Tyr174 (VAV1 pY174) Antibody |
|||
abx333478-100ul | Abbexa | 100 ul | EUR 467 |
![]() Vav 1 Oncogene Phospho-Tyr160 (VAV1 pY160) Antibody |
|||
20-abx326674 | Abbexa |
|
|
![]() Vav 1 Oncogene Phospho-Tyr174 (VAV1 pY174) Antibody |
|||
20-abx327138 | Abbexa |
|
|
![]() Vav 1 Oncogene Phospho-Tyr174 (VAV1 pY174) Antibody |
|||
20-abx329104 | Abbexa |
|
|
![]() Proto-Oncogene Vav (VAV1) ELISA Kit |
|||
abx595617-96tests | Abbexa | 96 tests | EUR 637 |
![]() Mouse Proto- oncogene vav, Vav1 ELISA KIT |
|||
ELI-17706m | Lifescience Market | 96 Tests | EUR 865 |
![]() Bovine Proto- oncogene vav, VAV1 ELISA KIT |
|||
ELI-51386b | Lifescience Market | 96 Tests | EUR 928 |
![]() Human Proto- oncogene vav, VAV1 ELISA KIT |
|||
ELI-51387h | Lifescience Market | 96 Tests | EUR 824 |
![]() Human Proto-oncogene vav (VAV1) ELISA Kit |
|||
abx384219-96tests | Abbexa | 96 tests | EUR 911 |
![]() Proto-Oncogene Vav Phospho-Tyr174 (VAV1 pY174) Antibody |
|||
20-abx012571 | Abbexa |
|
|
![]() Rabbit Polyclonal antibody Anti-CRBN |
|||
Anti-CRBN | ImmunoStep | 50 µg | EUR 349 |
![]() Anti-VAV1 Antibody |
|||
A00691-1 | BosterBio | 100ul | EUR 397 |
Description: Rabbit Polyclonal Antibody for VAV1 Antibody (VAV1) detection. Tested with WB in Human, Mouse, Rat. |
![]() Rabbit VAV1 oncogene ELISA kit |
|||
E04V0079-192T | BlueGene | 192 tests | EUR 1270 |
Description: A sandwich ELISA for quantitative measurement of Rabbit VAV1 oncogene in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
![]() Rabbit VAV1 oncogene ELISA kit |
|||
E04V0079-48 | BlueGene | 1 plate of 48 wells | EUR 520 |
Description: A sandwich ELISA for quantitative measurement of Rabbit VAV1 oncogene in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
![]() Rabbit VAV1 oncogene ELISA kit |
|||
E04V0079-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
Description: A sandwich ELISA for quantitative measurement of Rabbit VAV1 oncogene in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
![]() Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human) |
|||
4-PAE929Hu01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3) |
![]() Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human) |
|||
4-PAE929Hu02 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3) |
![]() Vav 3 Oncogene (VAV3) Antibody |
|||
20-abx133365 | Abbexa |
|
|
![]() Vav 3 Oncogene (VAV3) Antibody |
|||
20-abx101251 | Abbexa |
|
|
![]() Vav 3 Oncogene (VAV3) Antibody |
|||
20-abx101252 | Abbexa |
|
|
![]() Vav 3 Oncogene (VAV3) Antibody |
|||
abx433439-200ul | Abbexa | 200 ul | EUR 384 |
![]() Polyclonal Goat anti-GST α-form |
|||
GST-ANTI-1 | Detroit R&D | 50 uL | EUR 280 |
![]() Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), APC |
|||
4-PAE929Hu01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with APC. |
![]() Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), Biotinylated |
|||
4-PAE929Hu01-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with Biotin. |
![]() Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), Cy3 |
|||
4-PAE929Hu01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with Cy3. |
![]() Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), FITC |
|||
4-PAE929Hu01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with FITC. |
![]() Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), HRP |
|||
4-PAE929Hu01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with HRP. |
![]() Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), PE |
|||
4-PAE929Hu01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with PE. |
![]() Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), APC |
|||
4-PAE929Hu02-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with APC. |
![]() Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), Biotinylated |
|||
4-PAE929Hu02-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with Biotin. |
![]() Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), Cy3 |
|||
4-PAE929Hu02-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with Cy3. |
![]() Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), FITC |
|||
4-PAE929Hu02-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with FITC. |
![]() Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), HRP |
|||
4-PAE929Hu02-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with HRP. |
![]() Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), PE |
|||
4-PAE929Hu02-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with PE. |
![]() Recombinant Vav 3 Oncogene (VAV3) |
|||
4-RPE929Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Vav 3 Oncogene expressed in: E.coli |
![]() Recombinant Vav 3 Oncogene (VAV3) |
|||
4-RPE929Hu02 | Cloud-Clone |
|
|
Description: Recombinant Human Vav 3 Oncogene expressed in: E.coli |
![]() Anti-Vav antibody |
|||
STJ96227 | St John's Laboratory | 200 µl | EUR 197 |
Description: Rabbit polyclonal to Vav. |
![]() Vav Polyclonal Antibody |
|||
ES7488-100ul | ELK Biotech | 100ul | EUR 279 |
Description: A Rabbit Polyclonal antibody against Vav from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
![]() Vav Polyclonal Antibody |
|||
ES7488-50ul | ELK Biotech | 50ul | EUR 207 |
Description: A Rabbit Polyclonal antibody against Vav from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
![]() Vav Polyclonal Antibody |
|||
ABP56489-003ml | Abbkine | 0.03ml | EUR 158 |
Description: A polyclonal antibody for detection of Vav from Human, Mouse, Rat. This Vav antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Vav around the non-phosphorylation site of Y174 |
![]() Vav Polyclonal Antibody |
|||
ABP56489-01ml | Abbkine | 0.1ml | EUR 289 |
Description: A polyclonal antibody for detection of Vav from Human, Mouse, Rat. This Vav antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Vav around the non-phosphorylation site of Y174 |
![]() Vav Polyclonal Antibody |
|||
ABP56489-02ml | Abbkine | 0.2ml | EUR 414 |
Description: A polyclonal antibody for detection of Vav from Human, Mouse, Rat. This Vav antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Vav around the non-phosphorylation site of Y174 |
![]() Rabbit Anti-Human Vav1 Polyclonal Antibody, Phospho-Tyr174 |
|||
CPB-700RH | Creative Diagnostics | 100 ul | EUR 559 |
![]() Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), APC-Cy7 |
|||
4-PAE929Hu01-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with APC-Cy7. |
![]() Vav 3 Oncogene (VAV3) Polyclonal Antibody (Human), APC-Cy7 |
|||
4-PAE929Hu02-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Vav 3 Oncogene (VAV3). This antibody is labeled with APC-Cy7. |
![]() VAV1 Vav 1 Guanine Nucleotide Exchange Factor Human Recombinant Protein |
|||
PROTP15498 | BosterBio | Regular: 10ug | EUR 317 |
Description: VAV1 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 400 amino acids (189-565a.a) and having a molecular mass of 46.8kDa. |
![]() Human VAV1 oncogene ELISA kit |
|||
E01V0079-192T | BlueGene | 192 tests | EUR 1270 |
Description: A sandwich ELISA for quantitative measurement of Human VAV1 oncogene in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
![]() Human VAV1 oncogene ELISA kit |
|||
E01V0079-48 | BlueGene | 1 plate of 48 wells | EUR 520 |
Description: A sandwich ELISA for quantitative measurement of Human VAV1 oncogene in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
![]() Human VAV1 oncogene ELISA kit |
|||
E01V0079-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
Description: A sandwich ELISA for quantitative measurement of Human VAV1 oncogene in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
![]() Mouse VAV1 oncogene ELISA kit |
|||
E03V0079-192T | BlueGene | 192 tests | EUR 1270 |
Description: A sandwich ELISA for quantitative measurement of Mouse VAV1 oncogene in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
![]() Mouse VAV1 oncogene ELISA kit |
|||
E03V0079-48 | BlueGene | 1 plate of 48 wells | EUR 520 |
Description: A sandwich ELISA for quantitative measurement of Mouse VAV1 oncogene in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
![]() Mouse VAV1 oncogene ELISA kit |
|||
E03V0079-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
Description: A sandwich ELISA for quantitative measurement of Mouse VAV1 oncogene in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
![]() Rat VAV1 oncogene ELISA kit |
|||
E02V0079-192T | BlueGene | 192 tests | EUR 1270 |
Description: A sandwich ELISA for quantitative measurement of Rat VAV1 oncogene in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |